» 2017

Animal Health News & Notes for September 22, 2017 9/22/2017

printer friendly

***********************************
Brakke Consulting's
Animal Health News & Notes for September 22, 2017

Copyright © Brakke Consulting, Inc.
 
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
 
Brakke Consulting news
Pet Owner Channel Use Study – last week for early order
Market Research Reports
 
 
earnings news
Neogen

 
other news
Assisi Research Labs
Jaguar Health (MUMS)
Jaguar Health (stock offering)
Manna Pro
Merck
Petagon
PetzLife Products
Royal DSM
Sonoma Pharmaceuticals
World Pet Care Products Company
 

***********************************
BRAKKE CONSULTING, INC.
PET OWNER CHANNEL USE STUDY
LAST WEEK FOR EARLY ORDER DISCOUNT

Channel strategy has become more critical than ever before for marketers of pet products and services.   The new Pet Owner Channel Use Study provides up-to-the minute data and well as long-term perspective to provide you actionable data to use in designing marketing and sales channel strategies. Product categories included:

 • Wellness and therapeutic pet foods
 • Flea and tick control
 • Heartworm prevention
 • Dental treats and products
 • Pain management and other chronic-use medications
 • Joint health supplements
 • Pet Health insurance

The study will be fielded in October 2017, with completion by January 4, 2018.  Companies that order by September 29, 2017 and pay by October 30 receive a $1,000 early-order discount.  Upon publication, the price of the study is $12,500.

For more information about the study or to order, contact John Volk, Senior Consultant, john@volkonline.com or info@brakkeconsulting.com.

 
www.BrakkeConsulting.com
 

***********************************
COMPANY EARNINGS RELEASES

• Neogen Corporation announced results for the first quarter of its 2018 fiscal year ended Aug. 31. First quarter revenues increased 14% to $95 million; net income increased 21% to $11.9 million. Animal Safety revenues were $48.5 million, an increase of 9% compared to the comparable prior-year period. (company press release)

***********************************
SOUTHWEST VETERINARY SYMPOSIUM
SAN ANTONIO, TX AT THE HENRY B. GONZALEZ CONVENTION CENTER
SEPTEMBER 21- 24, 2017

Southwest Veterinary Symposium is a partnership of the Arkansas, Louisiana, New Mexico, Oklahoma and Texas VMAs to provide continuing education for veterinary professionals in the southwest region and the nation. Symposium profits are returned to the partner states VMAs. SWVS will be held in September 2017 in San Antonio, Texas at the Henry B. Gonzalez Convention Center. SWVS offers more than 375 hours of quality continuing education courses for veterinary professionals. This will be our 15th anniversary and you won’t want to miss out on all the fun!

For more information or to register for the conference, go to www.swvs.org

**********************************
COMPANY NEWS RELEASES

• Merck Animal Health announced the release of the Whisper Veterinary Stethoscope System,  a tool specifically designed to evaluate lung disease severity for more accurate diagnosis of bovine respiratory disease (BRD). Merck Animal Health acquired the rights to Whisper from Geissler Companies in 2016. (Cattlenetwork.com)

• Royal DSM announced the launch of Hy-D, a performance product is for sows and faster growing pigs being raised indoors. Hy-D is a proprietary metabolite of vitamin D, 25-OH-D3 that supplements vitamin D3. (Animal Pharm)

• Jaguar Health, Inc. announced that the FDA’s Center for Veterinary Medicine (CVM) has indicated that the use of Canalevia (crofelemer) for treatment of exercise-induced diarrhea in dogs qualifies as a “minor use”, per the requirements of The Minor Use and Minor Species Animal Health Act of 2004 (MUMS Act). Jaguar previously received MUMS designation for Canalevia for use in dogs with chemotherapy-induced diarrhea. (company press release)

• Jaguar Health, Inc. announced that it intends to offer and sell shares of its common stock, subject to market and other conditions, in an underwritten public offering. The Company intends to use the net proceeds from the offering for commercialization of its human prescription drug product as well as for general corporate purposes and working capital. (company press release)

• The FDA announced that it issued a MUMS designation to Assisi Research Laboratories for the Dactinomycin for use in the treatment of relapsed or refractory lymphoma in dogs. (FDA)

• Manna Pro Products, LLC, announced it has acquired PetzLife Products Inc., a provider of all-natural oral care products for dogs and cats. In addition to its Complete Oral Care product line, PetzLife also markets dental chews, tooth and finger brushes, tick and ear mite repellents, wound care products, and waterless shampoos and conditioners. Financial terms were not disclosed. (PetProductNews)

• JAPAN  Sonoma Pharmaceuticals announced it has launched its MicrocynAH line of skin, eye and wound healing products in Japan.  The products will be exclusively distributed in Japan by World Pet Care Products Company, under the direction of the Asian distributor Petagon. (Animal Pharm)
 
***********************************
ANIMAL HEALTH NEWS

• US - PET EDUCATION  The Animal Medical Center (AMC) in New York announced the launch of the Usdan Institute for Animal Health Education to help educate owners on all aspects of their pet’s health. The Usdan Institute for Animal Health Education will focus on three areas of education: animal health, public health as it relates to animals, and the human-animal bond. (Veterinary Practice News)
 
************************************
BRAKKE CONSULTING, INC.
MARKET RESEARCH REPORTS
Information to keep you ahead of the competition
 

Brakke Consulting is an industry leader in timely market research on topics of high interest to stakeholders in the animal health, pet and veterinary markets.  Some of our recent or soon-to-be-published reports include:

• Cancer in Dogs and Cats (September 2017)
• Pain Management Products for Dogs and Cats (April 2017)
• New Strategies for Livestock and Poultry Production (January 2017)
• Manufacturer Sales Force Effectiveness Study (December 2016)
• US Veterinary Generic Drugs Market (September 2016)
• US Flea Control and Heartworm Markets (coming December 2017)
• Distributor Sales Force Effectiveness Study (coming December 2017)
• Pet Owner Channel Use Study (coming January 2018) 
• Equine Market MegaStudy IV (coming January 2018)

Prices for reports vary. For more information about these or other reports, visit our website at or contact us at 972.243.4033 or info@BrakkeConsulting.com.

www.BrakkeConsulting.com
 
************************************
BRAKKE CONSULTING VIEWPOINT

Industry news to report this week is a bit shallow.  We assume many companies are focusing on closing out the final few days of the third quarter of 2017 and completing the budgeting process for 2018.  Early feedback from several companies would indicate that the industry will have a reasonably strong third quarter which, if correct, would indicate that 2017 will finish strong. 

We hope you noted in the newsletter the list of current and future industry studies that we have recently published or will be available soon to provide insights into several areas of importance to many companies’ future growth.  If you have questions on any of the studies, please contact the Dallas office or one of our consultants.

Have a great weekend and start enjoying the fall!

Ron Brakke
 
**********************************
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.

For more information about Brakke Consulting's services and syndicated studies, visit our website at www.brakkeconsulting.com.
 
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX  75234    USA